阿菲麥克斯公司
US ˙ OTCPK

簡介

本頁面提供了有關 Ted W Love 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Ted W Love已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:GILD / Gilead Sciences, Inc. Director 5,484
US:JAZZ / Jazz Pharmaceuticals plc Director 1,527
US:RPRX / Royalty Pharma plc Director 53,848
US:SGEN / Seagen Inc Director 0
US:GBT / Global Blood Therapeutics Inc. President and CEO, Director 0
Director 0
US:FOLD / Amicus Therapeutics, Inc. Director 18,574
US:CASC / Cascadian Therapeutics, Inc. Director 0
US:KBIO / KaloBios Pharmaceuticals, Inc. Director 5,000
US:SNTS / Santarus, Inc Director 0
US:MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF Director 62,451
US:ONXX / Onyx Pharmaceuticals Inc EVP, R&D and Tech. Operations 77,756
US:AFFY / Affymax, Inc. Director 12,000
US:ABIO / ARCA biopharma, Inc. Director 7,500
如何解讀這些圖表

以下圖表顯示了在Ted W Love進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

AFFY / Affymax, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AFFY / Affymax, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AFFY / Affymax, Inc. Insider Trades
AFFY / Affymax, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AFFY / Affymax, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

AFFY / Affymax, Inc. Insider Trades
MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AFFY / Affymax, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF Insider Trades
MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AFFY / Affymax, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

MSTX / Tidal Trust II - Defiance Daily Target 2X Long MSTR ETF Insider Trades
RPRX / Royalty Pharma plc內部人士買入 - 短期收益分析

在這一部分,我們分析了在 AFFY / Affymax, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

RPRX / Royalty Pharma plc Insider Trades
RPRX / Royalty Pharma plc內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 AFFY / Affymax, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

RPRX / Royalty Pharma plc Insider Trades
歷史內部人交易

該表格顯示了由 Ted W Love 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-04 2026-04-30 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 1,146 5,484 26.42
2026-03-02 2026-02-26 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
A - Award 1,527 1,527
2025-05-14 2025-05-13 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
A - Award 7,614 53,848 16.47
2025-05-08 2025-05-07 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 1,516 4,338 53.72
2024-06-10 2024-06-07 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
A - Award 9,293 46,234 25.16
2024-05-09 2024-05-08 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 2,310 2,822 451.17
2024-02-06 2024-02-02 4 GILD GILEAD SCIENCES, INC.
Common Stock
A - Award 512 512
2023-12-15 2023-12-14 4 SGEN Seagen Inc.
Common Stock
D - Sale to Issuer -4,255 0 -100.00 229.00 -974,395
2023-06-26 2023-06-23 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
A - Award 7,747 36,941 26.54
2023-06-02 2023-05-31 4 SGEN Seagen Inc.
Common Stock
A - Award 2,044 6,748 43.45
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -2,500 0 -100.00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -2,500 0 -100.00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -102,000 0 -100.00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -119,650 0 -100.00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -119,650 0 -100.00
2022-10-06 2022-10-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -576,318 0 -100.00
2022-09-29 2022-09-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 18,291 576,318 3.28 16.40 299,972 9,451,615
2022-09-29 2022-09-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift 17,650 119,650 17.30
2022-09-29 2022-09-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift 17,650 119,650 17.30
2022-09-29 2022-09-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift -35,300 558,027 -5.95
2022-09-29 2022-09-09 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift -221,200 593,327 -27.16
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -9,200 814,527 -1.12 68.15 -626,980 55,510,015
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,109 823,727 1.12
2022-09-06 2022-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,444 814,618 1.17
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -10,018 805,174 -1.23 32.40 -324,583 26,087,638
2022-08-03 2022-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 20,205 815,192 2.54
2022-06-24 2022-06-24 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
A - Award 6,328 29,194 27.67
2022-05-17 2022-05-13 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
A - Award 3,676 3,676
2022-05-17 2022-05-13 4 SGEN Seagen Inc.
Common Stock
A - Award 1,503 4,704 46.95
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to buy)
A - Award 118,090 118,090
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 72,877 72,877
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 72,877 72,877
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,445 56,667 -14.29
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4,074 794,987 -0.51 29.87 -121,690 23,746,262
2022-03-03 2022-03-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,445 799,061 1.20
2022-03-03 2022-02-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 839 789,616 0.11 25.37 21,285 20,032,558
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -8,955 35,820 -20.00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -11,250 22,500 -33.33
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 0 -100.00
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -10,531 788,777 -1.32 29.33 -308,874 23,134,829
2022-02-03 2022-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 29,955 799,308 3.89
2022-01-06 2016-07-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -24,821 1,117,815 -2.17 3.40 -84,391 3,800,571
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -8,955 44,775 -16.67
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -11,250 33,750 -25.00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 9,750 -50.00
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -14,853 789,413 -1.85 27.33 -405,932 21,574,657
2021-09-24 2021-08-01 4/A GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 29,955 804,266 3.87
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,444 66,112 -12.50
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4,683 794,174 -0.59 29.85 -139,788 23,706,094
2021-09-03 2021-09-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 9,444 798,857 1.20
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -8,955 44,775 -16.67
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -11,250 33,750 -25.00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 9,750 -50.00
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -14,853 789,413 -1.85 27.33 -405,932 21,574,657
2021-08-03 2021-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 29,955 804,266 3.87
2021-06-29 2021-06-25 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
A - Award 5,726 22,866 33.41
2021-05-18 2021-05-14 4 SGEN Seagen Inc.
Non-Qualified Stock Option (right to buy)
A - Award 3,462 3,462
2021-05-18 2021-05-14 4 SGEN Seagen Inc.
Common Stock
A - Award 1,402 3,201 77.93
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 75,556 75,556
2021-03-03 2021-03-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 132,433 132,433
2021-03-03 2021-02-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 370 774,311 0.05 36.21 13,398 28,037,801
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -8,955 53,730 -14.29
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -11,250 45,000 -20.00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 19,500 -33.33
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -12,063 0 -100.00
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -17,893 773,941 -2.26 49.49 -885,525 38,302,340
2021-02-03 2021-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 42,018 791,834 5.60
2020-08-18 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Non-Qualified Stock Option (right to buy)
A - Award 4,460 4,460
2020-08-18 2020-08-17 4 SGEN SEATTLE GENETICS INC /WA
Common Stock
A - Award 1,799 1,799
2020-08-17 2020-08-13 4 RPRX Royalty Pharma plc
Class A Ordinary Shares
A - Award 7,280 17,280 72.80
2020-08-10 3 RPRX Royalty Pharma plc
Class A Ordinary Shares
20,000
2020-08-10 3 RPRX Royalty Pharma plc
Class A Ordinary Shares
20,000
2020-08-10 3 RPRX Royalty Pharma plc
Class A Ordinary Shares
20,000
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -8,955 62,685 -12.50
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -11,250 56,250 -16.67
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 29,250 -25.00
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -12,062 12,063 -50.00
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -20,834 749,816 -2.70 67.48 -1,405,878 50,597,584
2020-08-04 2020-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 42,017 770,650 5.77
2020-08-04 2020-06-12 4 GBT Global Blood Therapeutics, Inc.
Common Stock
G - Gift -306,000 728,633 -29.58
2020-07-02 2020-07-02 4 PTLA PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -14,812 0 -100.00
2020-07-02 2020-07-02 4 PTLA PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy)
D - Sale to Issuer -11,377 0 -100.00 0.06 -683
2020-07-02 2020-07-02 4 PTLA PORTOLA PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -15,575 0 -100.00 18.00 -280,350
2020-06-15 2020-06-12 4 PTLA PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 11,377 11,377
2020-06-15 2020-06-12 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
A - Award 7,281 15,575 87.79
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 18,574 18,574
2020-06-08 2020-06-04 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 5,855 131,000 4.68
2020-06-03 2020-06-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 141,400 141,400
2020-04-29 2020-04-28 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -40,000 1,034,633 -3.72 80.00 -3,200,160 82,774,779
2020-04-29 2020-04-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,517 1,074,633 -0.14 80.63 -122,320 86,650,560
2020-04-29 2020-04-27 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,300 1,076,150 -0.12 81.15 -105,494 87,328,712
2020-02-20 2020-02-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,818 1,077,450 -0.17 70.92 -128,940 76,416,956
2020-02-20 2020-02-18 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -2,189 1,079,268 -0.20 70.22 -153,721 75,790,732
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 114,190 114,190
2020-02-04 2020-02-03 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 71,640 71,640
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -11,250 67,500 -14.29
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 39,000 -20.00
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -12,063 24,125 -33.33
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -14,169 1,081,457 -1.29 65.26 -924,669 70,575,884
2020-02-04 2020-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 33,063 1,095,626 3.11
2020-02-04 2020-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 579 1,062,563 0.05 36.68 21,238 38,974,811
2020-01-23 2020-01-22 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -1,031 1,061,984 -0.10 82.45 -85,011 87,565,785
2020-01-23 2020-01-22 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -32,150 1,063,015 -2.94 81.85 -2,631,600 87,011,817
2020-01-23 2020-01-22 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -6,819 1,095,165 -0.62 81.01 -552,436 88,723,916
2020-01-23 2020-01-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -523 1,101,984 -0.05 83.56 -43,703 92,083,436
2020-01-23 2020-01-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -10,166 1,102,507 -0.91 82.78 -841,562 91,267,734
2020-01-23 2020-01-21 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -29,311 1,112,673 -2.57 81.98 -2,402,837 91,213,928
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -87,500 0 -100.00
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -43,383 1,141,984 -3.66 76.88 -3,335,285 87,795,730
2019-12-17 2019-12-13 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 87,500 1,185,367 7.97
2019-12-09 2019-12-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -3,716 1,097,867 -0.34 76.15 -282,973 83,602,572
2019-12-09 2019-12-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -23,152 1,101,583 -2.06 77.72 -1,799,327 85,612,828
2019-12-09 2019-12-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -6,800 1,124,735 -0.60 76.78 -522,122 86,360,078
2019-12-09 2019-12-06 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -6,332 1,131,535 -0.56 75.73 -479,512 85,689,222
2019-12-09 2019-12-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -6,750 1,137,867 -0.59 75.39 -508,873 85,782,200
2019-12-09 2019-12-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -8,525 1,144,617 -0.74 74.66 -636,478 85,457,334
2019-12-09 2019-12-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -996 1,153,142 -0.09 74.08 -73,784 85,424,759
2019-12-09 2019-12-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -12,442 1,154,138 -1.07 75.35 -937,475 86,961,528
2019-12-09 2019-12-05 4 GBT Global Blood Therapeutics, Inc.
Common Stock
S - Sale X -11,287 1,166,580 -0.96 74.62 -842,262 87,052,883
2019-10-02 2019-09-18 4 PTLA PORTOLA PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 14,812 14,812
2019-10-02 2019-09-18 4 PTLA PORTOLA PHARMACEUTICALS INC
Common Stock
A - Award 8,294 8,294
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -11,250 78,750 -12.50
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 48,750 -16.67
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -12,062 36,188 -25.00
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -16,394 1,177,867 -1.37 54.25 -889,374 63,899,285
2019-08-05 2019-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 33,062 1,194,261 2.85
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Stock Options (right to buy)
A - Award 19,473 19,473
2019-07-01 2019-06-27 4 FOLD AMICUS THERAPEUTICS, INC.
Common Stock
A - Award 6,250 125,145 5.26
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -35,000 87,500 -28.57
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -17,354 1,161,199 -1.47 58.51 -1,015,383 67,941,753
2019-04-10 2019-04-08 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 35,000 1,178,553 3.06
2019-04-10 2019-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 579 1,143,553 0.05 36.68 21,238 41,945,524
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 58,500 -14.29
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -12,063 48,250 -20.00
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 90,000 90,000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 145,000 145,000
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -7,814 1,142,974 -0.68 48.44 -378,510 55,365,661
2019-02-05 2019-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 21,813 1,150,788 1.93
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -9,750 68,250 -12.50
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -12,062 60,313 -16.67
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -10,816 1,128,975 -0.95 43.15 -466,710 48,715,271
2018-08-03 2018-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 21,812 1,139,791 1.95
2018-07-17 2018-07-16 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
M - Exercise -12,194 132,806 -8.41
2018-07-17 2018-07-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 12,194 1,117,979 1.10 16.40 199,982 18,334,856
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 8,912 8,912
2018-06-11 2018-06-07 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 3,081 8,895 52.99
2018-03-13 2018-03-09 4 CASC Cascadian Therapeutics, Inc.
Restricted Stock Units
D - Sale to Issuer -13,927 0 -100.00
2018-03-13 2018-03-09 4 CASC Cascadian Therapeutics, Inc.
Common Stock
U - Other -37,394 0 -100.00
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -35,000 122,500 -22.22
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -17,353 1,105,785 -1.55 62.30 -1,081,092 68,890,406
2018-02-16 2018-02-14 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 35,000 1,123,138 3.22
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 78,000 78,000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 122,000 122,000
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -12,063 72,375 -14.29
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -5,981 1,087,142 -0.55 59.60 -356,468 64,793,663
2018-02-02 2018-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 12,063 1,093,123 1.12
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -35,000 157,500 -18.18
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -17,353 1,081,060 -1.58 57.90 -1,004,739 62,593,374
2018-02-02 2018-01-31 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 35,000 1,098,413 3.29
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -35,000 192,500 -15.38
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -17,354 1,063,413 -1.61 58.15 -1,009,135 61,837,466
2018-01-26 2018-01-24 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 35,000 1,080,767 3.35
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -35,000 227,500 -13.33
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -17,083 1,045,767 -1.61 52.10 -890,024 54,484,461
2018-01-18 2018-01-16 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 35,000 1,062,850 3.41
2017-09-26 2017-09-24 4 CASC Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
M - Exercise -2,375 0 -100.00
2017-09-26 2017-09-24 4 CASC Cascadian Therapeutics, Inc.
Common Stock
F - Taxes -594 37,394 -1.56 3.94 -2,340 147,332
2017-09-26 2017-09-24 4 CASC Cascadian Therapeutics, Inc.
Common Stock
M - Exercise 2,375 37,988 6.67
2017-08-14 2017-08-11 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award -262,500 262,500 -50.00
2017-08-14 2017-08-11 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -124,106 1,027,850 -10.77 3.40 -421,340 3,489,551
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
M - Exercise -12,062 84,438 -12.50
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
F - Taxes -4,533 1,151,956 -0.39 25.10 -113,778 28,914,096
2017-08-03 2017-08-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
M - Exercise 12,062 1,156,489 1.05
2017-06-27 2017-06-24 4 CASC Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
M - Exercise -9,058 0 -100.00
2017-06-27 2017-06-24 4 CASC Cascadian Therapeutics, Inc.
Common Stock
F - Taxes -2,265 35,613 -5.98 3.78 -8,562 134,617
2017-06-27 2017-06-24 4 CASC Cascadian Therapeutics, Inc.
Common Stock
M - Exercise 9,058 37,878 31.43
2017-06-16 2017-06-13 4/A FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5,814 147,814 4.09
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 16,236 16,236
2017-06-15 2017-06-13 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 5,814 5,814
2017-06-13 2017-06-12 4 CASC Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
M - Exercise -2,148 0 -100.00
2017-06-13 2017-06-12 4 CASC Cascadian Therapeutics, Inc.
Common Stock
F - Taxes -537 28,820 -1.83 3.34 -1,794 96,259
2017-06-13 2017-06-12 4 CASC Cascadian Therapeutics, Inc.
Common Stock
M - Exercise 2,148 29,357 7.89
2017-06-13 2017-06-09 4 CASC Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
A - Award 13,927 13,927
2017-02-14 2017-01-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 1,413 1,144,427 0.12 13.73 19,400 15,712,983
2017-02-14 2016-07-31 5 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 378 1,143,014 0.03 15.20 5,746 17,373,813
2017-02-10 2016-06-06 5 CASC Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
M - Exercise -2,723 0 -100.00
2017-02-10 2016-06-06 5 CASC Cascadian Therapeutics, Inc.
Common Stock
F - Taxes -681 27,209 -2.44 7.38 -5,026 200,802
2017-02-10 2016-06-06 5 CASC Cascadian Therapeutics, Inc.
Common Stock
M - Exercise 2,723 27,890 10.82
2017-02-03 2017-02-02 4 CASC Cascadian Therapeutics, Inc.
Common Stock
P - Purchase 23,000 27,209 546.45 4.24 97,520 115,366
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Stock Option (right to buy)
A - Award 145,000 145,000
2017-01-19 2017-01-17 4 GBT Global Blood Therapeutics, Inc.
Restricted Stock Units
A - Award 96,500 96,500
2016-12-16 2016-07-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
D - Sale to Issuer -24,821 1,139,815 -2.13 3.40 -84,391 3,875,371
2016-06-28 2016-06-24 4 CASC Cascadian Therapeutics, Inc.
Restricted Share Unit (RSU)
A - Award 54,347 54,347
2016-06-13 2016-06-09 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2016-02-03 2016-02-01 4 GBT Global Blood Therapeutics, Inc.
Common Stock
A - Award 1,925 1,142,636 0.17 16.09 30,973 18,385,013
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 2,500 2,500 20.00 50,000 50,000
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 2,500 2,500 20.00 50,000 50,000
2016-01-07 2015-08-17 4 GBT Global Blood Therapeutics, Inc.
Common Stock
P - Purchase 5,000 1,140,711 0.44 20.00 100,000 22,814,220
2015-09-28 2015-09-24 4 ONTY Oncothyreon Inc.
Restricted Share Unit (RSU)
A - Award 14,245 14,245
2015-09-09 2015-09-05 4 ONTY Oncothyreon Inc.
Restricted Share Unit (RSU)
M - Exercise -17,341 0 -100.00
2015-09-09 2015-09-05 4 ONTY Oncothyreon Inc.
Common Stock
F - Taxes -4,336 13,005 -25.00 3.25 -14,092 42,266
2015-09-09 2015-09-05 4 ONTY Oncothyreon Inc.
Common Stock
M - Exercise 17,341 17,341
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,157,139
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,849,996
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,337,139
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,234,996
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,234,996
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,157,139
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,849,996
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,337,139
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,234,996
2015-08-11 3 GBT Global Blood Therapeutics, Inc.
Common Stock
1,234,996
2015-07-14 2015-07-10 4 KBIO KALOBIOS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 5,000 5,000
2015-06-16 2015-06-12 4 ONTY Oncothyreon Inc.
Restricted Share Unit (RSU)
A - Award 12,886 12,886
2015-06-12 2015-06-10 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 20,000 20,000
2014-12-15 2014-11-25 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 32,000 142,000 29.09 7.83 250,637 1,112,201
2014-06-20 2014-06-18 4 KBIO KALOBIOS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 20,000 20,000
2014-06-16 2014-06-12 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2014-06-10 2014-06-06 4 ONTY Oncothyreon Inc.
Restricted Share Unit (RSU)
A - Award 16,339 16,339
2014-03-12 2014-03-12 4 FOLD AMICUS THERAPEUTICS INC
Common Stock
A - Award 110,000 110,000 2.21 243,100 243,100
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -35,000 0 -100.00 26.76 -936,600
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -32,500 0 -100.00 25.27 -821,275
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -34,500 0 -100.00 26.68 -920,460
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -32,000 0 -100.00 28.67 -917,440
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -34,500 0 -100.00 28.88 -996,360
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -34,500 0 -100.00 25.27 -871,815
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Stock Options (right to buy)
D - Sale to Issuer -34,500 0 -100.00 10.07 -347,415
2014-01-06 2014-01-02 4 SNTS SANTARUS INC
Common Stock
U - Other -335,500 0 -100.00 32.00 -10,736,000
2013-09-06 2013-09-05 4 ONTY Oncothyreon Inc.
Restricted Share Unit (RSU)
A - Award 17,341 17,341
2013-09-06 3 ONTY Oncothyreon Inc.
Common Stock
0
2013-06-21 2013-06-19 4 MSTX Mast Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 62,451 62,451
2013-06-17 2013-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Options (right to buy)
A - Award 15,000 15,000
2013-06-12 2013-06-11 4 SNTS SANTARUS INC
Stock Option (right to buy)
A - Award 34,500 34,500
2013-05-02 2013-04-30 4 KBIO KALOBIOS PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 15,000 15,000
2012-12-19 2012-12-18 4 SNTS SANTARUS INC
Common Stock
P - Purchase 185,000 335,500 122.92 10.88 2,012,800 3,650,240
2012-09-07 2012-09-05 4 ANX ADVENTRX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 14,171 14,171
2012-09-07 2012-09-05 4 ANX ADVENTRX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 18,895 18,895
2012-07-27 2012-07-25 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
S - Sale X -5,241 77,756 -6.31 73.97 -387,687 5,751,759
2012-06-18 2012-06-13 4 AFFY AFFYMAX INC
Stock Option (Right to Buy)
A - Award 12,000 12,000
2012-06-15 2012-06-13 4 FOLD AMICUS THERAPEUTICS INC
Stock Option (right to buy)
A - Award 30,000 30,000
2012-06-14 2012-06-13 4 SNTS SANTARUS INC
Stock Option (right to buy)
A - Award 34,500 34,500
2012-04-03 2012-04-02 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer X -757 82,997 -0.90 36.58 -27,689 3,035,831
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 49,700 49,700
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 17,150 83,754 25.75
2012-04-03 2012-03-30 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
A - Award 9,800 66,604 17.25
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -34,500 0 -100.00
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -34,500 0 -100.00
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -34,500 0 -100.00
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -32,000 0 -100.00
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Stock Options (right to buy)
M - Exercise -15,000 0 -100.00
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Common Stock
M - Exercise 34,500 150,500 29.74 2.47 85,215 371,735
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Common Stock
M - Exercise 34,500 116,000 42.33 2.38 82,110 276,080
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Common Stock
M - Exercise 32,000 81,500 64.65 1.18 37,760 96,170
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Common Stock
M - Exercise 34,500 49,500 230.00 2.02 69,690 99,990
2012-03-12 2012-03-09 4 SNTS SANTARUS INC
Common Stock
M - Exercise 15,000 15,000 3.00 45,000 45,000
2012-02-03 2012-02-01 4 ONXX ONYX PHARMACEUTICALS INC
Common Stock
F - Taxes -2,098 56,804 -3.56 41.98 -88,074 2,384,632
2009-03-03 2009-02-27 4 ABIO ARCA biopharma, Inc.
Option to Purchase Common Stock
A - Award 7,500 7,500
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)